Nicolas J. Dickgreber
Rheine, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort.
Journal: Infection
Published: December 04, 2025
Treatment Outcomes of Endoscopic Lung Volume Reduction with Valves in Advanced Lung Emphysema Patients Are Largely Independent of Body Mass Index: Data from the German Lung Emphysema Registry.
Journal: Respiration; international review of thoracic diseases
Published: July 26, 2025
Reply to Trudzinski et al. Comment on "Akil et al. Nonintubated versus Intubated Lung Volume Reduction Surgery in Patients with End-Stage Lung Emphysema and Hypercapnia. J. Clin. Med. 2023, 12, 3750".
Journal: Journal of clinical medicine
Published: May 09, 2025
Nonintubated versus Intubated Lung Volume Reduction Surgery in Patients with End-Stage Lung Emphysema and Hypercapnia.
Journal: Journal of clinical medicine
Published: April 04, 2023
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 23, 2022
Lung Volume Reduction Surgery Reduces Pulmonary Arterial Hypertension Associated With Severe Lung Emphysema and Hypercapnia.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
Published: April 13, 2022
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 28, 2022
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 14, 2021
Molecular approach to the classification of chronic fibrosing lung disease-there and back again.
Journal: Virchows Archiv : an international journal of pathology
Published: August 06, 2020
Veno-Venous Extracorporeal Lung Support as a Bridge to or Through Lung Volume Reduction Surgery in Patients with Severe Hypercapnia.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
Published: August 03, 2020
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer.
Journal: Current medical research and opinion
Published: May 25, 2019
Last Updated: 09/26/2026